Johns Hopkins: Cervical fluid samples gathered during routine Papanicolaou
(Pap) tests are the basis of a new screening test for endometrial and
ovarian cancers developed by researchers at the Johns Hopkins Kimmel Cancer Center. PapSEEK detects mutations in DNA that have been identified for
specific cancers sooner. Earlier detection of cancer could lead to
earlier treatment and potentially better outcomes for patients. The test uses cervical fluid samples to look for mutations in
18 genes, which are highly or commonly mutated in endometrial or ovarian
cancers, and aneuploidy, the presence of abnormal numbers of
chromosomes in cells. The researchers said their results showed the
potential for mutation-based diagnostics to detect endometrial and
ovarian cancers earlier.
Only good, independent and reliable information about health from experts.
Showing posts with label endometrial cancer. Show all posts
Showing posts with label endometrial cancer. Show all posts
Wednesday, April 18, 2018
Friday, December 23, 2016
Long-Term Anti-Inflammatory Drug Use May Increase Cancer-Related Deaths for Certain Patients
Columbus: Regular use of over-the-counter non-steroidal inflammatory drugs
(NSAIDs) such as aspirin and ibuprofen is associated with an increased
risk of dying in patients diagnosed with Type 1
endometrial cancers, according to a new population-based study led by
The Ohio State University Comprehensive Cancer Center – Arthur G. James
Cancer Hospital and Richard J. Solove Research Institute (OSUCCC –
James). In this observational study, a multi-institutional team of cancer
researchers sought to understand the association of regular NSAID use
and the risk of dying from endometrial cancer among a cohort of more
than 4,000 patients.
Wednesday, November 2, 2016
Cervical and endometrial cancer patients report fewer side effects and better quality of life with IMRT
ASTRO: Patients with cervical and endometrial cancer have fewer
gastrointestinal and genitourinary side effects and experience better
quality of life when treated with intensity-modulated radiation therapy
(IMRT) than with conventional radiation therapy (RT), according to
research presented today at the 58th Annual Meeting of the American
Society for Radiation Oncology (ASTRO). Women receiving IMRT reported
significantly fewer bowel and bladder problems than those receiving
conventional radiation treatment.
Tuesday, May 12, 2015
Potential for a more personalised approach to womb cancer
Manchester doctors have helped show that high-risk
womb cancer patients can be genetically profiled to allow them to
receive more appropriate treatment. Traditionally, patients with endometrial cancer – cancer of
the womb lining - have their disease risk classified using a combination
of clinical and tissue characteristics, including their age and the
growth and invasion of their tumour.Tuesday, March 24, 2015
Could a simple test predict endometrial cancer?
Mayo Clinic: Researchers at Mayo Clinic have shown that it is possible to detect endometrial cancer
using tumor DNA picked up by ordinary tampons. The new approach
specifically examines DNA samples from vaginal secretions for the
presence of chemical “off” switches — known as methylation — that can
disable genes that normally keep cancer in check.
Wednesday, January 14, 2015
Metabolic Syndrome is Associated With Increased Endometrial Cancer Risk Independent of Being Overweight/Obese
AACR. US: Women age 65 or older who had
metabolic syndrome—a common disorder characterized by a number of
medical conditions, including low levels of “good” cholesterol and high
levels of fats called triglycerides—were at increased risk of
endometrial cancer, and this increased risk was independent of being
overweight or obese, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Endometrial cancer
American Cancer Society: Endometrial cancer is a cancer that starts in the endometrium, the inner lining of the uterus (womb). The picture below shows where the uterus is located. The uterus is a hollow organ, about the size and shape of a medium-sized pear. The uterus is where a fetus grows and develops when a woman is pregnant. The uterus has 2 main parts (see picture above). The cervix is the lower end of the uterus that extends into the vagina. The upper part of the uterus is called the body or the corpus. (Corpus is the Latin word for body.) Although the cervix is technically part of the uterus, when people talk about the uterus, they usually mean the body, not the cervix.
Subscribe to:
Posts (Atom)


